Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Artificial Intelligence
The Technology Conundrum
“Technology is a tool. How it’s applied is up to us.” – Wendell Wallach As human beings, our daily decisions impact the lives of others. To guide these decisions,… Continue reading →

Read the article
no
KOL Engagement
Navigating HCP Digital Engagement: Best Practices
As medical education evolves, the need for effective digital engagement strategies is also growing. In order to ensure that healthcare professionals (HCPs) have access to the most up-to-date information… Continue reading →

Read the article
no
Artificial Intelligence
The Power of Data: Three Ways to Rethink AI Hallucinations
In this new content series, H1’s Senior Director of Strategic Commercial Engagement, Robert Consalvo, writes about leveraging generative AI for business, digital health, life sciences, biotech and pharma and the… Continue reading →

Read the article
no
Artificial Intelligence
Balancing Creativity and Accuracy in Artificial Intelligence
In the realm of AI, balancing creativity and accuracy is a critical consideration, especially when developing AI systems for business applications. While creativity adds novelty and innovation to outputs,… Continue reading →

Read the article
no
Commercialization Drug Development
What Payer Trends Can Tell Us About Medication Adherence
One of the most important aspects of monitoring payer trends is getting an accurate picture of patient utilization. Understanding which treatments are being utilized, by whom, and for what… Continue reading →

Read the article
no
Diversity & Inclusion Drug Development
Improving Oncology Clinical Trials for Accelerated Approval
In March of 2023, the U.S. Food and Drug Administration (FDA) issued draft guidance, Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics, regarding clinical trial design specific… Continue reading →

Read the article
no

‹1 2 345 6 7 ›»

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕